Beijing Historical Income Statement

603392 Stock   72.94  0.92  1.28%   
Historical analysis of Beijing Wantai income statement accounts such as Net Interest Income of 84 M, Interest Income of 83.6 M or Interest Expense of 4 M can show how well Beijing Wantai Biological performed in making a profits. Evaluating Beijing Wantai income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Beijing Wantai's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Beijing Wantai Biological latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Beijing Wantai Biological is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beijing Wantai Biological. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Beijing Income Statement Analysis

Beijing Wantai Biological Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Beijing Wantai shareholders. The income statement also shows Beijing investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Beijing Wantai Income Statement Chart

At present, Beijing Wantai's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 84 M, whereas Interest Income is forecasted to decline to about 83.6 M.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Beijing Wantai Biological minus its cost of goods sold. It is profit before Beijing Wantai operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Beijing Wantai Biological. It is also known as Beijing Wantai overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Net Income Applicable To Common Shares

The net income that remains after preferred dividends have been deducted, available to common shareholders.
Most accounts from Beijing Wantai's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Beijing Wantai Biological current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beijing Wantai Biological. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At present, Beijing Wantai's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 84 M, whereas Interest Income is forecasted to decline to about 83.6 M.
 2021 2022 2023 2024 (projected)
Gross Profit4.9B10.0B4.7B3.4B
Total Revenue5.8B11.2B5.5B4.0B

Beijing Wantai income statement Correlations

0.370.010.960.960.970.670.990.990.670.70.910.911.00.990.67-0.90.670.58
0.37-0.170.510.50.50.910.410.390.910.870.540.580.390.390.92-0.350.910.77
0.01-0.170.050.040.030.010.030.020.00.030.080.050.020.02-0.01-0.040.00.11
0.960.510.051.01.00.790.990.980.80.830.980.990.980.980.78-0.920.790.76
0.960.50.041.01.00.790.990.980.790.830.990.990.980.980.78-0.930.790.76
0.970.50.031.01.00.790.990.980.790.820.980.990.980.980.78-0.930.790.76
0.670.910.010.790.790.790.720.71.01.00.830.850.70.71.0-0.691.00.89
0.990.410.030.990.990.990.721.00.720.750.950.951.01.00.71-0.930.720.66
0.990.390.020.980.980.980.71.00.70.740.940.941.01.00.69-0.930.70.63
0.670.910.00.80.790.791.00.720.70.990.830.850.70.711.0-0.681.00.88
0.70.870.030.830.830.821.00.750.740.990.870.870.730.740.99-0.730.990.89
0.910.540.080.980.990.980.830.950.940.830.870.990.940.940.81-0.940.820.82
0.910.580.050.990.990.990.850.950.940.850.870.990.940.940.83-0.910.840.85
1.00.390.020.980.980.980.71.01.00.70.730.940.941.00.69-0.930.70.63
0.990.390.020.980.980.980.71.01.00.710.740.940.941.00.69-0.930.70.64
0.670.92-0.010.780.780.781.00.710.691.00.990.810.830.690.69-0.651.00.87
-0.9-0.35-0.04-0.92-0.93-0.93-0.69-0.93-0.93-0.68-0.73-0.94-0.91-0.93-0.93-0.65-0.68-0.67
0.670.910.00.790.790.791.00.720.71.00.990.820.840.70.71.0-0.680.88
0.580.770.110.760.760.760.890.660.630.880.890.820.850.630.640.87-0.670.88
Click cells to compare fundamentals

Beijing Wantai Account Relationship Matchups

Beijing Wantai income statement Accounts

201920202021202220232024 (projected)
Tax Provision6.5M82.6M244.9M719.4M146.9M171.5M
Net Interest Income7.2M(11.4M)3.6M33.7M80.0M84.0M
Interest Income8.6M1.2B9.8M42.2M88.0M83.6M
Interest Expense1.0M1.7M5.7M7.7M6.9M4.0M
Selling General Administrative356.9M807.3M1.7B3.3B1.7B1.2B
Total Revenue1.2B2.4B5.8B11.2B5.5B4.0B
Gross Profit852.9M1.9B4.9B10.0B4.7B3.4B
Other Operating Expenses9.3M12.5M26.7M51.3M59.0M61.9M
Operating Income221.3M825.7M2.4B5.6B1.6B1.5B
Net Income From Continuing Ops210.3M681.8M2.1B4.9B1.2B1.3B
Ebit149.3M724.7M2.2B5.3B6.1B6.4B
Research Development166.0M314.3M681.8M1.1B1.2B1.3B
Cost Of Revenue330.9M442.1M817.7M1.2B792.1M595.9M
Total Operating Expenses962.5M1.5B3.3B5.6B3.9B2.4B
Income Before Tax216.8M764.5M2.3B5.6B1.4B1.5B
Net Income Applicable To Common Shares208.9M677.0M2.0B4.7B5.4B5.7B
Net Income208.9M677.0M2.0B4.7B1.2B1.3B
Income Tax Expense6.5M82.6M244.9M719.4M827.3M868.7M
Minority Interest21.9M26.7M(57.7M)(127.5M)1.2M1.2M
Ebitda298.4M850.6M2.4B5.7B6.6B6.9B
Reconciled Depreciation80.5M84.5M105.3M151.9M231.5M120.5M

Currently Active Assets on Macroaxis

Other Information on Investing in Beijing Stock

Beijing Wantai Biological Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Beijing Wantai shareholders. The income statement also shows Beijing investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).